{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:53:35Z","timestamp":1793962415028,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771681"],"award-info":[{"award-number":["81771681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Six Elite Units Foundation","award":["WSW-058"],"award-info":[{"award-number":["WSW-058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10620-020-06518-6","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T05:03:43Z","timestamp":1596517423000},"page":"2272-2282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial\u2013Mesenchymal Transition"],"prefix":"10.1007","volume":"66","author":[{"given":"Xiaoling","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianru","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-7318","authenticated-orcid":false,"given":"Xiaorong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"6518_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semcancer.2018.05.002","volume":"55","author":"W Wang","year":"2019","unstructured":"Wang W, Kandimalla R, Huang H, et al. Molecular subtyping of colorectal cancer: recent progress, new challenges and emerging opportunities. Semin Cancer Biol. 2019;55:37\u201352.","journal-title":"Semin Cancer Biol"},{"key":"6518_CR2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.20892\/j.issn.2095-3941.2015.0103","volume":"13","author":"K Tariq","year":"2016","unstructured":"Tariq K, Ghias K. Colorectal cancer carcinogenesis: a review of mechanisms. Cancer Biol Med. 2016;13:120\u2013135.","journal-title":"Cancer Biol Med"},{"key":"6518_CR3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2174\/1389450119666180803122744","volume":"19","author":"M Wlodarczyk","year":"2018","unstructured":"Wlodarczyk M, Wlodarczyk J, Siwinski P, Sobolewska-Wlodarczyk A, Fichna J. Genetic molecular subtypes in optimizing personalized therapy for metastatic colorectal cancer. Curr Drug Targets. 2018;19:1731\u20131737.","journal-title":"Curr Drug Targets"},{"key":"6518_CR4","doi-asserted-by":"crossref","first-page":"e35065","DOI":"10.1371\/journal.pone.0035065","volume":"7","author":"T Lv","year":"2012","unstructured":"Lv T, Yuan D, Miao X, et al. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer. PLoS ONE. 2012;7:e35065.","journal-title":"PLoS ONE"},{"key":"6518_CR5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/0008-5472.CAN-17-1236","volume":"78","author":"C Liu","year":"2018","unstructured":"Liu C, Liu L, Chen X, et al. LSD1 stimulates cancer-associated fibroblasts to drive Notch3-dependent self-renewal of liver cancer stem-like cells. Cancer Res. 2018;78:938\u2013949.","journal-title":"Cancer Res"},{"key":"6518_CR6","doi-asserted-by":"crossref","first-page":"e0118002","DOI":"10.1371\/journal.pone.0118002","volume":"10","author":"S Nagasawa","year":"2015","unstructured":"Nagasawa S, Sedukhina AS, Nakagawa Y, et al. LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition. PLoS ONE. 2015;10:e0118002.","journal-title":"PLoS ONE"},{"key":"6518_CR7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.25349","volume":"128","author":"S Hayami","year":"2011","unstructured":"Hayami S, Kelly JD, Cho HS, et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer. 2011;128:574\u2013586.","journal-title":"Int J Cancer"},{"key":"6518_CR8","doi-asserted-by":"crossref","first-page":"e70077","DOI":"10.1371\/journal.pone.0070077","volume":"8","author":"Z Huang","year":"2013","unstructured":"Huang Z, Li S, Song W, et al. Lysine-specific demethylase 1 (LSD1\/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt\/beta-catenin pathway by down-regulating Dickkopf-1 (DKK1). PLoS ONE. 2013;8:e70077.","journal-title":"PLoS ONE"},{"key":"6518_CR9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2217\/epi-2017-0022","volume":"9","author":"A Hosseini","year":"2017","unstructured":"Hosseini A, Minucci S. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer. Epigenomics. 2017;9:1123\u20131142.","journal-title":"Epigenomics"},{"key":"6518_CR10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/med.21350","volume":"35","author":"YC Zheng","year":"2015","unstructured":"Zheng YC, Ma J, Wang Z, et al. A systematic review of histone lysine-specific demethylase 1 and its inhibitors. Med Res Rev. 2015;35:1032\u20131071.","journal-title":"Med Res Rev"},{"key":"6518_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fgene.2018.00427","volume":"9","author":"V Miranda-Goncalves","year":"2018","unstructured":"Miranda-Goncalves V, Lameirinhas A, Henrique R, Jeronimo C. Metabolism and epigenetic interplay in cancer: regulation and putative therapeutic targets. Front Genet. 2018;9:427.","journal-title":"Front Genet"},{"key":"6518_CR12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/cas.13004","volume":"107","author":"S Hino","year":"2016","unstructured":"Hino S, Kohrogi K, Nakao M. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells. Cancer Sci. 2016;107:1187\u20131192.","journal-title":"Cancer Sci"},{"key":"6518_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/2211536602666140110234046","volume":"3","author":"S Bajan","year":"2014","unstructured":"Bajan S, Hutvagner G. Regulation of miRNA processing and miRNA mediated gene repression in cancer. Microrna. 2014;3:10\u201317.","journal-title":"Microrna"},{"key":"6518_CR14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","volume":"13","author":"Z Li","year":"2014","unstructured":"Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13:622\u2013638.","journal-title":"Nat Rev Drug Discov"},{"key":"6518_CR15","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1002\/jcp.27806","volume":"234","author":"M Sarvizadeh","year":"2019","unstructured":"Sarvizadeh M, Malekshahi ZV, Razi E, Sharifi H, Moussavi N, Taghizadeh M. MicroRNA: a new player in response to therapy for colorectal cancer. J Cell Physiol. 2019;234:8533\u20138540.","journal-title":"J Cell Physiol"},{"key":"6518_CR16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-07-5194","volume":"68","author":"K Kozaki","year":"2008","unstructured":"Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008;68:2094\u20132105.","journal-title":"Cancer Res"},{"key":"6518_CR17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1741-7015-6-14","volume":"6","author":"J Silber","year":"2008","unstructured":"Silber J, Lim DA, Petritsch C, et al. miR-124 and miR-137-3p inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.","journal-title":"BMC Med"},{"key":"6518_CR18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bjc.2016.379","volume":"116","author":"X Li","year":"2017","unstructured":"Li X, Chen W, Zeng W, Wan C, Duan S, Jiang S. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP. Br J Cancer. 2017;116:66\u201376.","journal-title":"Br J Cancer"},{"key":"6518_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-5-29","volume":"5","author":"E Bandres","year":"2006","unstructured":"Bandres E, Cubedo E, Agirre X, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29.","journal-title":"Mol Cancer"},{"key":"6518_CR20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u2013408.","journal-title":"Methods"},{"key":"6518_CR21","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/ijc.28091","volume":"133","author":"K Althoff","year":"2013","unstructured":"Althoff K, Beckers A, Odersky A, et al. MiR-137-3p functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. Int J Cancer. 2013;133:1064\u20131073.","journal-title":"Int J Cancer"},{"key":"6518_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biochi.2017.02.010","volume":"137","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhang X, Yu B, Hu R, Hao L. Oncogene LSD1 is epigenetically suppressed by miR-137-3p overexpression in human non-small cell lung cancer. Biochimie. 2017;137:12\u201319.","journal-title":"Biochimie"},{"key":"6518_CR23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00432-018-2733-2","volume":"144","author":"S Carvalho","year":"2018","unstructured":"Carvalho S, Freitas M, Antunes L, et al. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer. J Cancer Res Clin Oncol. 2018;144:2127\u20132137.","journal-title":"J Cancer Res Clin Oncol"},{"key":"6518_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41598-017-17913-x","volume":"8","author":"T Boulding","year":"2018","unstructured":"Boulding T, McCuaig RD, Tan A, et al. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer. Sci Rep. 2018;8:73.","journal-title":"Sci Rep"},{"key":"6518_CR25","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1038\/onc.2017.267","volume":"36","author":"S Ambrosio","year":"2017","unstructured":"Ambrosio S, Sacca CD, Amente S, Paladino S, Lania L, Majello B. Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway. Oncogene. 2017;36:6701\u20136711.","journal-title":"Oncogene"},{"key":"6518_CR26","doi-asserted-by":"crossref","first-page":"14572","DOI":"10.18632\/oncotarget.3990","volume":"6","author":"S Amente","year":"2015","unstructured":"Amente S, Milazzo G, Sorrentino MC, et al. Lysine-specific demethylase (LSD1\/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma. Oncotarget. 2015;6:14572\u201314583.","journal-title":"Oncotarget"},{"key":"6518_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175\u2013180.","journal-title":"Science"},{"key":"6518_CR28","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1038\/ncomms10347","volume":"7","author":"Y Kim","year":"2016","unstructured":"Kim Y, Nam HJ, Lee J, et al. Methylation-dependent regulation of HIF-1alpha stability restricts retinal and tumour angiogenesis. Nat Commun. 2016;7:10347.","journal-title":"Nat Commun"},{"key":"6518_CR29","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1074\/jbc.M113.537050","volume":"289","author":"W Li","year":"2014","unstructured":"Li W, Zhang X, Zhuang H, et al. MicroRNA-137 is a novel hypoxia-responsive microRNA that inhibits mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX. J Biol Chem. 2014;289:10691\u201310701.","journal-title":"J Biol Chem"},{"key":"6518_CR30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13:97\u2013110.","journal-title":"Nat Rev Cancer"},{"key":"6518_CR31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00441-014-1912-y","volume":"356","author":"VK Mishra","year":"2014","unstructured":"Mishra VK, Johnsen SA. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression. Cell Tissue Res. 2014;356:617\u2013630.","journal-title":"Cell Tissue Res"},{"key":"6518_CR32","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.18632\/oncotarget.1875","volume":"5","author":"U Bedi","year":"2014","unstructured":"Bedi U, Mishra VK, Wasilewski D, Scheel C, Johnsen SA. Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer. Oncotarget. 2014;5:2016\u20132029.","journal-title":"Oncotarget"},{"key":"6518_CR33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.tig.2017.08.004","volume":"33","author":"N Skrypek","year":"2017","unstructured":"Skrypek N, Goossens S, De Smedt E, Vandamme N, Berx G. Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity. Trends Genet. 2017;33:943\u2013959.","journal-title":"Trends Genet"},{"key":"6518_CR34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u2013196.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6518_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ajcp\/111.1.29","volume":"111","author":"J Gofuku","year":"1999","unstructured":"Gofuku J, Shiozaki H, Tsujinaka T, et al. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol. 1999;111:29\u201337.","journal-title":"Am J Clin Pathol"},{"key":"6518_CR36","doi-asserted-by":"crossref","first-page":"e85591","DOI":"10.1371\/journal.pone.0085591","volume":"9","author":"S Tamim","year":"2014","unstructured":"Tamim S, Vo DT, Uren PJ, Qiao M, et al. Genomic analyses reveal broad impact of miR-137-3p on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells. PLoS ONE. 2014;9:e85591.","journal-title":"PLoS ONE"},{"key":"6518_CR37","doi-asserted-by":"crossref","first-page":"44543","DOI":"10.1038\/srep44543","volume":"7","author":"T Chen","year":"2017","unstructured":"Chen T, Cai SL, Li J, et al. Mecp2-mediated epigenetic silencing of miR-137-3p contributes to colorectal adenoma-carcinoma sequence and tumor progression via relieving the suppression of c-Met. Sci Rep. 2017;7:44543.","journal-title":"Sci Rep"},{"key":"6518_CR38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/BJ20121360","volume":"449","author":"L Jin","year":"2013","unstructured":"Jin L, Hanigan CL, Wu Y, et al. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner. Biochem J. 2013;449:459\u2013468.","journal-title":"Biochem J"},{"key":"6518_CR39","doi-asserted-by":"crossref","first-page":"12558","DOI":"10.18632\/oncotarget.3726","volume":"6","author":"AR Smith","year":"2015","unstructured":"Smith AR, Marquez RT, Tsao WC, et al. Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression. Oncotarget. 2015;6:12558\u201312573.","journal-title":"Oncotarget"},{"key":"6518_CR40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-016-0415-y","volume":"35","author":"P Dong","year":"2016","unstructured":"Dong P, Xiong Y, Watari H, et al. MiR-137-3p and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells. J Exp Clin Cancer Res. 2016;35:132.","journal-title":"J Exp Clin Cancer Res"},{"key":"6518_CR41","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.celrep.2016.05.050","volume":"15","author":"H Luo","year":"2016","unstructured":"Luo H, Shenoy AK, Li X, et al. MOF acetylates the histone demethylase LSD1 to suppress epithelial-to-mesenchymal transition. Cell Rep. 2016;15:2665\u20132678.","journal-title":"Cell Rep"},{"key":"6518_CR42","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1038\/onc.2010.234","volume":"29","author":"T Lin","year":"2010","unstructured":"Lin T, Ponn A, Hu X, Law BK, Lu J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene. 2010;29:4896\u20134904.","journal-title":"Oncogene"},{"key":"6518_CR43","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1038\/oncsis.2017.66","volume":"6","author":"I Daugaard","year":"2017","unstructured":"Daugaard I, Sanders KJ, Idica A, et al. miR-151a induces partial EMT by regulating E-cadherin in NSCLC cells. Oncogenesis. 2017;6:e366.","journal-title":"Oncogenesis"},{"key":"6518_CR44","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1016\/j.clbc.2018.02.002","volume":"18","author":"N Yamashita","year":"2018","unstructured":"Yamashita N, Tokunaga E, Iimori M, et al. Epithelial paradox: clinical significance of coexpression of E-cadherin and vimentin with regard to invasion and metastasis of breast cancer. Clin Breast Cancer. 2018;18:e1003\u2013e1009.","journal-title":"Clin Breast Cancer"},{"key":"6518_CR45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/cancers11030324","volume":"11","author":"B Majello","year":"2019","unstructured":"Majello B, Gorini F, Sacca CD, Amente S. Expanding the role of the histone lysine-specific demethylase LSD1 in cancer. Cancers (Basel). 2019;11:324.","journal-title":"Cancers (Basel)"},{"key":"6518_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12935-016-0308-3","volume":"16","author":"T Kohnoh","year":"2016","unstructured":"Kohnoh T, Hashimoto N, Ando A, et al. Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lung cancers. Cancer Cell Int. 2016;16:33.","journal-title":"Cancer Cell Int"},{"key":"6518_CR47","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2174\/1381612821666141211145610","volume":"21","author":"JQ Wang","year":"2015","unstructured":"Wang JQ, Wu KJ. Epigenetic regulation of epithelial-mesenchymal transition by hypoxia in cancer: targets and therapy. Curr Pharm Des. 2015;21:1272\u20131278.","journal-title":"Curr Pharm Des"},{"key":"6518_CR48","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/onc.2017.158","volume":"36","author":"JY Lee","year":"2017","unstructured":"Lee JY, Park JH, Choi HJ, et al. LSD1 demethylates HIF1alpha to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis. Oncogene. 2017;36:5512\u20135521.","journal-title":"Oncogene"},{"key":"6518_CR49","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1093\/nar\/gky449","volume":"46","author":"L Bao","year":"2018","unstructured":"Bao L, Chen Y, Lai HT, et al. Methylation of hypoxia-inducible factor (HIF)-1alpha by G9a\/GLP inhibits HIF-1 transcriptional activity and cell migration. Nucleic Acids Res. 2018;46:6576\u20136591.","journal-title":"Nucleic Acids Res"},{"key":"6518_CR50","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.1158\/0008-5472.CAN-06-1699","volume":"66","author":"H Tanaka","year":"2006","unstructured":"Tanaka H, Yamamoto M, Hashimoto N, et al. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res. 2006;66:11263\u201311270.","journal-title":"Cancer Res"},{"key":"6518_CR51","first-page":"4693","volume":"60","author":"P Birner","year":"2000","unstructured":"Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000;60:4693\u20134696.","journal-title":"Cancer Res"},{"key":"6518_CR52","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3390\/ijms19123733","volume":"19","author":"C Molinari","year":"2018","unstructured":"Molinari C, Marisi G, Passardi A, Matteucci L, De Maio G, Ulivi P. Heterogeneity in colorectal cancer: a challenge for personalized medicine? Int J Mol Sci. 2018;19:3733.","journal-title":"Int J Mol Sci"},{"key":"6518_CR53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-019-0811-9","volume":"12","author":"Y Fang","year":"2019","unstructured":"Fang Y, Liao G, Yu B. LSD1\/KDM1A inhibitors in clinical trials: advances and prospects. J Hematol Oncol. 2019;12:129.","journal-title":"J Hematol Oncol"},{"key":"6518_CR54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm.2661","volume":"18","author":"T Schenk","year":"2012","unstructured":"Schenk T, Chen WC, Gollner S, et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med. 2012;18:605\u2013611.","journal-title":"Nat Med"},{"key":"6518_CR55","doi-asserted-by":"crossref","first-page":"549\u2013563 e519","DOI":"10.1016\/j.cell.2018.05.052","volume":"174","author":"W Sheng","year":"2018","unstructured":"Sheng W, LaFleur MW, Nguyen TH, et al. LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade. Cell. 2018;174:549\u2013563 e519.","journal-title":"Cell"},{"key":"6518_CR56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1634\/theoncologist.2019-0176","volume":"25","author":"MA Morse","year":"2020","unstructured":"Morse MA, Hochster H, Benson A. Perspectives on treatment of metastatic colorectal cancer with immune checkpoint inhibitor therapy. Oncologist. 2020;25:33\u201345.","journal-title":"Oncologist"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06518-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:08Z","timestamp":1628035208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06518-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6518"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06518-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"6 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}